Insider Transactions Reported by 16 Insiders of Armata Pharmaceuticals, Inc.

Symbol
ARMP on NYSE
Industry
Biological Products, (No Diagnostic Substances)
Location
5005 Mcconnell Ave, Los Angeles, CA

There are no Buy or Sell transactions made by insiders since 12/9/2024

Armata Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Deborah Birx Chief Executive Officer, Director $493K Jul 10, 2025
Richard Rychlik Corporate Controller and PFO $50K Mar 14, 2024
Pierre Kyme Chief Business Officer $20.5K Mar 14, 2025
Innoviva, Inc. Director, 10%+ Owner Jan 10, 2023
Todd Patrick Director Apr 13, 2022
Joseph M. Patti Director Feb 5, 2025
Jules Haimovitz Director Feb 5, 2025
Kostas D. Odysseas Director Feb 5, 2025
Duane Alfred Morris VP of Operations Apr 13, 2022
Brian Varnum President and CEO Apr 13, 2022
Robin Kramer Director Feb 5, 2025
Todd C. Peterson Director Feb 5, 2025
Julianne Averill Chief Financial Officer May 2, 2023
Erin Butler Vice President,Finance & Admin Jul 1, 2022
David Duane House SVP, Finance, and PFO Feb 5, 2025
Sarah Schlesinger Director Feb 5, 2025

Recent Insider Transactions by Companies or Individuals for Armata Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.